Global Depression Drugs Market is Expected to Reach $18 Billion, by 2024, Says Variant Market Research Global Depression Drug Market is estimated to reach $18 billion by 2024; growing at a CAGR of 2.6% from 2016 to 2024. Depression has emerged as one of the most common yet serious mental disorders among people globally. Depression is caused by combination of genetics, biological, environment and psychological factors. According to WHO published in 2016, estimated 350 million people have been affected and depression can lead to suicide. Over 800000 people die due to suicide every year, making it the second leading cause of death in 15-29 year old’s. Depression is more common in women than men. Depression drugs works by fixing chemical imbalance, especially, lack of serotonin in the brain. Although effective treatments are available, many individuals with depression do not have access to treatment or do not take treatment, mainly due to lack of knowledge and social stigma. Browse
Complete
Report
@
https://www.variantmarketresearch.com/report-
categories/pharmaceuticals/depression-drugs-market
Growing geriatric population, increase in the knowledge regarding depression and rising number of generic drug market are expected to drive the market. Moreover, support from government organizations could also support the growth of market. However, lack of resources, lack of trained healthcare providers and social stigma could be a barrier for the growth of market. Research and Variant Market Research
development and Untapped markets could provide an opportunity for the market in upcoming years. Get Sample Copy of This Report @ http://bit.ly/2pZLVUZ
The market is segmented based on the product type, application and geography. Product type is further segmented into Tricyclic Antidepressants, Serotonin-Norepinephrine Inhibitors, Atypical Antipsychotics,
Selective
Serotonin
Reuptake
Inhibitors,
Benzodiazepines,
Tetracyclic
Antidepressants, Monoamine Oxidase Inhibitors and others. Furthermore, application is segmented into clinics and hospitals and research centers. Based on geography, the depression drug market is segmented into North America, Europe, Asia-Pacific and Rest of World. The U.S., Mexico and Canada are covered under North America wherein Europe covers France, Germany, UK, Spain and rest of Europe. Asia-Pacific covers China, India, Japan, South Korea and Rest of Asia Pacific. Rest of the World (RoW) covers South America, Middle East and Africa. Scope of Depression Drugs Market Product Type Segments •
Tricyclic Antidepressants
•
Serotonin-Norepinephrine Inhibitors
Variant Market Research
•
Atypical Antipsychotics
•
Selective Serotonin Reuptake Inhibitors
•
Benzodiazepines, Tetracyclic Antidepressants
•
Monoamine Oxidase Inhibitors
•
Others
Application Segments •
Clinics and Hospitals
•
Research centers
Geographical Segments •
•
•
•
North America o
US
o
Canada
o
Mexico
Europe o
Germany
o
France
o
United Kingdom
o
Spain
o
Others
Asia-Pacific o
China
o
India
o
Japan
o
South Korea
o
Others
RoW o
South America
o
Middle East
o
Africa
Table of Content
Variant Market Research
Chapter 1. Prefix 1.1. Market Scope 1.2. Report Description 1.3. Research Methodology 1.3.1 Primary Research 1.3.2 Secondary Research 1.3.3 In-house Data Modeling Chapter 2. Executive Summary Chapter 3. Market Outline 3.1 Market Inclination, Trend, Outlook and Viewpoint 3.2 Market Share Analysis: Company’s Competitive Scenario 3.3 Value Chain Analysis 3.4 Market Dynamics 3.4.1 Drivers 3.4.1.1 Impact Analysis 3.4.2. Restraints 3.4.2.1 Impact Analysis 3.4.3 Opportunities 3.5 Porter’s five forces analysis 3.5.1 Factors Impact Analysis …. Chapter 7. Company Profiles 7.1 H. Lund beck, Merck & Co. 7.2 SK Biopharmaceuticals 7.3 Novartis 7.4 AstraZeneca 7.5 Forest Laboratories 7.6 Naurex 7.7 GlaxoSmithKline 7.8 Eli Lilly and Co.
Contact Us: VARIANT MARKET RESEARCH LLP Web: https://www.variantmarketresearch.com/ Variant Market Research
USA Office: 649 Mission St., 5th Floor, San Francisco, CA 94105, United States. Tel: +1-415-680-2785 Fax: +1-415-680-2786 Email: help@variantmarketresearch.com India Office (Corporate Headquarter): Office No. FL No.7, Prakash Developers, Survey no 34/A5, Wadgaon Sheri, Nagar Road, Pune – 411014 Tel: +91 20 65337795
Variant Market Research